Editas grants new CMO Daniel Ory stock options for 950,000 shares at USD 3.03 each

• Editas Medicine granted new Chief Medical Officer Daniel Ory stock options for 950,000 shares, priced at USD 3.03 per share.
• Award vests over four years; 25% vests on the 15th day of the month after the first anniversary of his start date.
• Remaining options vest monthly thereafter, subject to continued service through each vesting date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Editas Medicine Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609090900PRIMZONEFULLFEED9823278) on September 09, 2026, and is solely responsible for the information contained therein.